- $572.13m
- $462.72m
Annual cashflow statement for Zura Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 6.85 | 3.55 | -60.6 | -52.4 | -68.7 |
| Depreciation | |||||
| Non-Cash Items | -7.71 | -6.22 | 40.4 | 22 | 7.42 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.236 | 1.6 | 5.12 | 2.31 | -3.63 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -1.1 | -1.07 | -15.1 | -28.1 | -64.8 |
| Capital Expenditures | — | — | -8 | -5.08 | -0.113 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -139 | 0 | — | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -139 | 0 | -8 | -5.08 | -0.113 |
| Financing Cash Flow Items | 141 | 0 | -1.18 | -0.944 | -7.37 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 141 | 0.356 | 121 | 110 | -2.16 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.729 | -0.715 | 98.2 | 76.7 | -67.1 |